Baxter International Inc.
- BAX
- NYSE
- Medical - Instruments & Supplies
- Dialysis/Renal Care
- Hospital/Medical Products
$24.51
Today −1.92%Quote Oct 20, 2026, 08:00 PM UTC
+6.89%over the last month
Max drawdown −4.9%From 1-month high −4.9%3 months +12.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Baxter International
Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services.
Where the money comes from
Q2 2026 revenue $2.96B
- Medical Products And Therapies$2.08B70.1%
- Healthcare Systems and Technologies$801.0M27.1%
- Other / not reported$83.0M2.8%
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NYSE
Employees
37,500
Market value
$12.67B
Quote Oct 20
Floor
$24.42
0.4% below price
Resistance
$25.20
2.8% above price
Price vs analyst targets
36 analysts
Lowest target
$20.00Highest target
$28.00
$20.00Highest target
$28.00
- Price $24.51
- Average target $23.60
- Analysts' target range
Analysts' average target sits about 4% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BAXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free